The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
lycera corporation | 195 |
merck & company | 39 |
lycera corporation | 33 |
merck & company | 1 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
pyrazolyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof | 31 | 2010 |
tetrahydronaphthyridine and related bicyclic compounds for inhibition of rorgamma activi… 🛈 | 18 | 2012 |
pyridonyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof | 17 | 2010 |
bicyclic sulfone compounds for inhibition of rorgamma activity and the treatment of dise… 🛈 | 16 | 2012 |
trifluoromethyl pyrazolyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof | 16 | 2013 |
tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of ro… 🛈 | 15 | 2012 |
tetrahydroquinoline sulfonamide and related compounds for use as agonists of rory and th… 🛈 | 11 | 2014 |
n-substituted pyrazolyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof | 10 | 2013 |
n- sulfonylated tetrahydroquinolines and related bicyclic compounds inhibition of rory a… 🛈 | 9 | 2010 |
adoptive cellular therapy using an agonist of retinoic acid receptor-related orphan rece… 🛈 | 9 | 2014 |